Danielle Fishel said she is feeling positive about her health while speaking exclusively with PEOPLE at iHeartRadio's 102.7 ...
A growing body of evidence suggests GLP-1 receptor agonists may improve survival as well as reduce chemotherapy-related toxicities in women with breast cancer.
Danielle Fishel has shared an update on her breast cancer battle. The Boy Meets World alum, 44, is looking to the future ...
The test is now ordered by breast surgeons or radiation oncologists in more than 85% of the top 50 U.S. cancer centers.
The Boy Meets World alum, who is now in remission after a difficult journey, said she has been feeling 'grateful' about her ...
In non-low-risk DCIS of the breast, the addition of a TBB of radiation following postoperative WBI is associated with reduced local recurrence.
The actress was diagnosed with ductal carcinoma in situ (DCIS), an early stage of breast cancer, in August last year. She ...
Prelude Corporation (PreludeDx®), a leader in precision diagnostics for early-stage breast cancer, today announced results from the first independent validation of AidaBreasttm, a novel multi-omic ...
Dilon Technologies, a leading provider of medical devices, has gained FDA approval for its MarginProbe(R) 2 system and is announcing its launch in the U.S. This is the next-generation device for ...
Innovative smart pill bottles significantly enhance adherence to oral adjuvant endocrine therapy in early-stage breast cancer ...
Medical Device Network on MSN
FDA approves Dilon’s intraoperative margin assessment device
The FDA has granted approval for Dilon Technologies’ MarginProbe 2, an intraoperative margin assessment device for breast ...
A breast cancer diagnosis is hard enough – what happens when a mother and daughter go through it at the same time?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback